ARATANA THERAPEUTICS, INC. — Form D

ARATANA THERAPEUTICS, INC. of KANSAS CITY, KS, a company, filed a Form D exempt-offering notice with the SEC on 2013-10-23. The offering totals $29.8M, of which $29.8M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Robert GerberDirectorCARLSBAD, CA
Jay Lichter, Ph.D.DirectorLa Jolla, CA
Ronald L Meeusen, Ph.D.DirectorBurr Ridge, IL
Linda L Rhodes, V.M.D., Ph.D.DirectorKansas City, KS
Steven L St. Peter, M.D.DirectorKansas City, KS
Craig L ToomanDirectorFar Hills, NJ
John L Vander VortDirectorBoston, MA
Ernst A Heinen, D.V.M., Ph.D.Executive OfficerKansas City, KS
Jay Lichter, Ph.D.Executive OfficerLa Jolla, CA
Louise A MawhinneyExecutive OfficerKansas City, KS
Linda L Rhodes, V.M.D., Ph.D.Executive OfficerKansas City, KS
Julia A StephanusExecutive OfficerKansas City, KS
Steven L St. Peter, M.D.Executive OfficerKansas City, KS
David RosenExecutive OfficerNew York, NY
Jay LichterDirectorLa Jolla, CA
Jay LichterExecutive OfficerLa Jolla, CA
Linda RhodesDirectorSan Francisco, CA
Linda RhodesExecutive OfficerSan Francisco, CA
Craig ToomanDirectorLondon, X0
Ron MeeusenDirectorEmeryville, CA
John Vander VortDirectorKansas City, KS
Steven St. PeterDirectorKansas City, KS
Steven St. PeterExecutive OfficerKansas City, KS
Ronald L. MeeusenDirectorKansas City, KS
Rip GerberDirectorKansas City, KS

Other filings by this issuer (3)

FiledFormOfferingSold
2012-12-28D$12.0M
2011-10-25D$15.5M
2011-01-07D$20.0M$10.0M

More